Lyn regulates creatine uptake in an imatinib-resistant CML cell line. [electronic resource]
Producer: 20200914Description: 129507 p. digitalISSN:- 1872-8006
- Antineoplastic Agents -- pharmacology
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Creatine -- metabolism
- Drug Resistance, Neoplasm -- drug effects
- Drug Screening Assays, Antitumor
- Humans
- Imatinib Mesylate -- pharmacology
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- metabolism
- Tumor Cells, Cultured
- src-Family Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.